• Info
  • Insider Ownership

Insider Trading & Ownership of Richard A. Heyman

Location
Del Mar, CA
Summary
The estimated net worth of Richard A. Heyman is at least $7.04M dollars as of 03 Oct 2025. Richard A. Heyman is the Director of Enliven Therapeutics, Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $4.53M. Richard A. Heyman is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $2.52M.
Signature
/s/ Christian Kuhlen, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when Richard A. Heyman files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Richard A. Heyman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN, IMRA Enliven Therapeutics, Inc. Director $4.53M 06 Feb 2025
ORIC Oric Pharmaceuticals, Inc. Director $2.52M 03 Oct 2025
RYZB RayzeBio, Inc. Director $0 26 Feb 2024
GRTS Gritstone bio, Inc. Director 17 Jun 2022
MTCR Metacrine, Inc. Director 18 May 2022
PMVP PMV Pharmaceuticals, Inc. Director 05 Jun 2025
KANT KINETA, INC./DE Director 02 Jun 2021

Insider Transactions Reported by Richard A. Heyman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.